Chengdu Easton Biopharmaceuticals Co's quarterly market cap
increased
from Sep. 2025 (¥9,769 Mil) to Dec. 2025 (¥10,866 Mil) and
increased
from Dec. 2025 (¥10,866 Mil) to Mar. 2026 (¥11,367 Mil).
Chengdu Easton Biopharmaceuticals Co's annual market cap
declined
from Dec. 2023 (¥7,659 Mil) to Dec. 2024 (¥5,319 Mil) but then
increased
from Dec. 2024 (¥5,319 Mil) to Dec. 2025 (¥10,866 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Chengdu Easton Biopharmaceuticals Co's Enterprise Value for Today is ¥7,682 Mil.
Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Chengdu Easton Biopharmaceuticals Co Market Cap Related Terms
Chengdu Easton Biopharmaceuticals Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chengdu Easton Biopharmaceuticals Co Market Cap Chart
SHSE:688513 vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, Chengdu Easton Biopharmaceuticals Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chengdu Easton Biopharmaceuticals Co Market Cap vs Biotechnology Industry
Chengdu Easton Biopharmaceuticals Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chengdu Easton Biopharmaceuticals Co (SHSE:688513) has a Market Cap of ¥9,091 Mil as of Jul. 09, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Chengdu Easton Biopharmaceuticals Co and its competitors. According to the industry distribution chart, Chengdu Easton Biopharmaceuticals Co ranks #241 out of 1421 companies in the Biotechnology industry, placing it in the top 17%.
Is Chengdu Easton Biopharmaceuticals Co's Market Cap too high?
Chengdu Easton Biopharmaceuticals Co's current Market Cap is ¥9,091 Mil. Based on the distribution chart, Chengdu Easton Biopharmaceuticals Co ranks #241 out of 1421 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Chengdu Easton Biopharmaceuticals Co has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chengdu Easton Biopharmaceuticals Co's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Chengdu Easton Biopharmaceuticals Co ranks #241 out of 1421 companies for Market Cap. This places Chengdu Easton Biopharmaceuticals Co in the top 17% of its industry — outperforming the majority of peers. The industry median Market Cap is 119.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.86, based on 1,421 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Chengdu Easton Biopharmaceuticals Co and its competitors. For the Biotechnology industry, the median Market Cap is 119.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chengdu Easton Biopharmaceuticals Co's current Market Cap is ¥9,091 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chengdu Easton Biopharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Chengdu Easton Biopharmaceuticals Co (SHSE:688513) is currently considered Fairly Valued. The stock's GF Value™ is ¥47.94, compared to a current price of ¥51.50 — trading 7.4% above its estimated fair value. The current Market Cap is ¥9,091 Mil. Chengdu Easton Biopharmaceuticals Co's overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Chengdu Easton Biopharmaceuticals Co (SHSE:688513), the current Market Cap is ¥9,091 Mil as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Overvalued in 2026?
Based on GuruFocus' analysis, Chengdu Easton Biopharmaceuticals Co stock appears to be overvalued.
The current stock price of ¥51.50 is trading 7.4% above its estimated GF Value™ of ¥47.94.
GuruFocus considers Chengdu Easton Biopharmaceuticals Co to be Fairly Valued.
Key valuation signals for SHSE:688513:
Market Cap: ¥9,091 Mil
GF Value™: ¥47.94 vs. price of ¥51.50 (7.4% above fair value)
No single metric tells the full story. See the SHSE:688513 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chengdu Easton Biopharmaceuticals Co Business Description
Chengdu Easton Biopharmaceuticals Co Ltd is engaged in research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The company's products range from Active Pharmaceutical Ingredient to finish dosage forms like capsules, tablets and injections, enabling us to take R&D discovery to industrial level, solving problems during the course of R&D, production and distribution. Its products are categorized under Active Pharmaceutical Ingredients and Fixed Dose Formulation.
95GF Score
Get the complete analysis for SHSE:688513
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688513 has been successfully added to your 
